Mode
Text Size
Log in / Sign up
N/A Completed N=420 Randomized Single-blind Treatment

A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting

Source: ClinicalTrials.gov NCT03986931 ↗
Enrolled (actual)
420
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcomePrimary: Difference in Change in Systolic Blood Pressure- 12 Months — -23.8; -19.6 mmHg

Summary

Bidirectional texting is an effective way to collect home blood pressure (BP) measurements from subjects, but collecting BP measurements and sending them to physicians does not necessarily lead to decreased BP. Pharmacist interventions have been successful in decreasing subject BP. However, pharmacists are expensive, and in successful interventions, spent a substantial amount of time collecting home BP measurements. In this study, a proven pharmacist intervention will be added to a bidirectional texting program to determine if a combined pharmacist-bidirectional texting intervention is successful at decreasing subject BP and increasing subject BP treatment intensification in a cost-effective manner. This study will be a cluster-randomized, controlled trial of a new intervention.

Outcome Measures

OutcomeResultp-value
PRIMARY
Difference in Change in Systolic Blood Pressure- 12 Months
-23.8; -19.6
SECONDARY
Difference in Change in Diastolic Blood Pressure- 12 Months
-9.1; -9.6
SECONDARY
Number of Medication Changes From 6 to 12 Months
0.59; 0.44
SECONDARY
Dollars Spent Per Patient for 12 Month Bidirectional Texting/Pharmacist Intervention
980.17; 838.95

Eligibility Criteria

Inclusion Criteria

  • Fluent in English or Spanish
  • Have a clinic measured blood pressure of > or = 145 mmHg and/or > or = 95 mmHg at two previous clinic visits or one previous clinic visit and on the day of enrollment
  • Must be a patient at Family Medicine, River Crossings, Scott Blvd, or Muscatine University of Iowa Clinics
  • Live in a zip code that is scored as a 4-10 on the Rural-Urban Commuting Area codes

Exclusion Criteria

  • Currently pregnant or planning to become pregnant in the next year
  • Upper arm circumference greater than 50 cm (20 in)
  • Prisoner status
  • Unable to provide own informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03986931). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search